Ray Dalio's CHE Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 5,062 shares of Chemed Corporation (CHE) worth $1.91 M, representing 0.01% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in CHE, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 21,620 shares. Largest reduction occurred in Q4 2024, reducing 12,207 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Chemed Corporation (CHE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Chemed Corporation (CHE) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -6,217 | Reduce 55.12% | 5,062 | $377.74 |
| Q4 2025 | +6,749 | Add 148.98% | 11,279 | $427.86 |
| Q3 2025 | +1,690 | Add 59.51% | 4,530 | $447.74 |
| Q2 2025 | -4,827 | Reduce 62.96% | 2,840 | $486.93 |
| Q1 2025 | -682 | Reduce 8.17% | 7,667 | $615.32 |
| Q4 2024 | -12,207 | Reduce 59.38% | 8,349 | $529.80 |
| Q3 2024 | -8,266 | Reduce 28.68% | 20,556 | $600.97 |
| Q2 2024 | +21,620 | Add 300.19% | 28,822 | $542.58 |
| Q1 2024 | -7,400 | Reduce 50.68% | 7,202 | $641.93 |
| Q4 2023 | -2,955 | Reduce 16.83% | 14,602 | $584.75 |
| Q3 2023 | +1,496 | Add 9.31% | 17,557 | $519.70 |
| Q2 2023 | -1,978 | Reduce 10.97% | 16,061 | $541.67 |
| Q1 2023 | -4,943 | Reduce 21.51% | 18,039 | $537.75 |
| Q4 2022 | -3,613 | Reduce 13.59% | 22,982 | $510.43 |
| Q3 2022 | +5,007 | Add 23.19% | 26,595 | $436.55 |
| Q2 2022 | -2,139 | Reduce 9.02% | 21,588 | $469.38 |
| Q1 2022 | +5,886 | Add 32.99% | 23,727 | $506.55 |
| Q4 2021 | +1,531 | Add 9.39% | 17,841 | $529.06 |
| Q3 2021 | +452 | Add 2.85% | 16,310 | $465.11 |
| Q2 2021 | +9,616 | Add 154.05% | 15,858 | $474.52 |
| Q1 2021 | -2,894 | Reduce 31.68% | 6,242 | $459.79 |
| Q4 2020 | +5,136 | Add 128.40% | 9,136 | $532.62 |
| Q3 2020 | +4,000 | New Buy | 4,000 | $480.25 |
Ray Dalio's Chemed Corporation Investment FAQs
Ray Dalio first purchased Chemed Corporation (CHE) in Q3 2020, acquiring 4,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Chemed Corporation (CHE) for 23 quarters since Q3 2020.
Ray Dalio's largest addition to Chemed Corporation (CHE) was in Q2 2024, adding 28,822 shares worth $15.64 M.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 5,062 shares of Chemed Corporation (CHE), valued at approximately $1.91 M.
As of the Q1 2026 filing, Chemed Corporation (CHE) represents approximately 0.01% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Chemed Corporation (CHE) was 28,822 shares, as reported at the end of Q2 2024.